p ikkα β (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
86
Structured Review
Cell Signaling Technology Inc
p ikkα β
P Ikkα β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ikk%CE%B1+%CE%B2/pmc12995874-16-0-3
Average 86 stars, based on 1 article reviews
P Ikkα β, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+ikk%CE%B1+%CE%B2/pmc12995874-16-0-3
Average 86 stars, based on 1 article reviews
p ikkα β - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Western Blot:Article Title: A HHEX/IKKα positive feedback loop promotes intestinal inflammation Article Snippet: LipofectamineTM 3000 was purchased from Invitrogen. .. Antibodies specific for the following proteins were used in this study: HHEX (MAB83771, R&D Systems, dilutions: 1:1000 for WB and 1:100 for IHC), IKKα (A2062, ABclonal, dilutions: 1:1000 for WB and 1:500 for IP), IKKβ (A19606, ABclonal, dilutions: 1:1000 for WB), IKKγ (A0917, ABclonal, dilutions: 1:1000 for WB), MID2 (PA5-117727, Invitrogen, dilutions: 1:1000 for WB), p-IKKα/β (2078S, Cell Signaling Technology ,dilutions: 1:1000 for WB), p-IκBα (AF1870, Beyotime, dilutions: 1:1000 for WB), IκBα (AF1282, Beyotime, dilutions: 1:1000 for WB), p-p65 (AN371, Beyotime, dilutions: 1:1000 for WB), p65 (AF1234, Beyotime, dilutions: 1:1000 for WB), NFκB2 (15503-1-AP, Proteintech, dilutions: 1:1000 for WB), TLE1(66216-1-lg, Proteintech, dilutions: 1:1000 for WB), NOD2(A25228, ABclonal, dilutions: 1:1000 for WB), GP2(GTX134145, GeneTex, dilutions: 1:100 for IF), HA (3724, Cell Signaling Technology, dilutions: 1:3000 for WB), FLAG (14793, Cell Signaling Technology, dilutions: 1:1000 for WB), MYC (2276, Cell Signaling Technology, dilutions: 1:1000 for WB), GFP (sc9996, Santa Cruz, dilutions: 1:1000 for WB), pan-Ser (sc-81514, Santa Cruz, dilutions: 1:1000 for WB), p-S213 (Sanyou Bio, dilutions: 1:1000 for WB), β-actin (A2228, Sigma‒Aldrich, dilutions: 1:10,000 for WB), Lamin B1(12987-1-AP, Proteintech, dilutions: 1:1000 for WB), β-tubulin (A12289, ABclonal, dilutions: 1:1000 for WB), and normal rabbit IgG (2729, Cell Signaling Technology, dilutions: 1:500 for IP). .. Description of the Preparation Method for p-S213 Antibody by Sanyou Bio: Stage 1: Peptide Design and Synthesis Two peptides targeting the protein of interest were designed and synthesized, each conjugated to keyhole limpet hemocyanin (KLH) and subjected to phosphorylation modification. Article Title: Negative feedback regulation of STING signaling by TAX1BP1-directed Golgiphagy. Article Snippet: HT-DNA (D6898) was purchased from Millipore-Sigma. .. Antibodies used for immunoblotting p-TBK1 (5483S), TBK1 (3504S), p-IRF3 (4947S), IRF3 (4302S), p-STING (50907S), Immunohistochemistry:Article Title: A HHEX/IKKα positive feedback loop promotes intestinal inflammation Article Snippet: LipofectamineTM 3000 was purchased from Invitrogen. .. Antibodies specific for the following proteins were used in this study: HHEX (MAB83771, R&D Systems, dilutions: 1:1000 for WB and 1:100 for IHC), IKKα (A2062, ABclonal, dilutions: 1:1000 for WB and 1:500 for IP), IKKβ (A19606, ABclonal, dilutions: 1:1000 for WB), IKKγ (A0917, ABclonal, dilutions: 1:1000 for WB), MID2 (PA5-117727, Invitrogen, dilutions: 1:1000 for WB), other:Article Title: Protective effect of Zymosan-A against radiation-induced premature ovarian insufficiency in a murine model Article Snippet: Article Title: Therapeutic Potential of Ruberythric Acid in Intestinal Inflammation and Barrier Function Reduction Article Snippet: Antibodies against lamin B1, inhibitor of NF-κB kinase subunit alpha (IKKα), p-IKKα/β, inhibitor of kappa B alpha (IκBα), p-IκBα, p-p65, p65, MLCK, and Membrane:Article Title: Tumor-derived S100A14 targeted astrocytes via TLR4 to Recruit myeloid-derived suppressor cells promoting brain metastasis and Curdione reversal effect. Article Snippet: Background: Brain metastasis (BrM) is the most common complication with the highest mortality in clinical tumor patients.. The underlying mechanisms of S100A14 in promoting tumor BrM remains unclear, and effective therapeutic compounds targeting S100A14 are currently unavailable.. Purpose: In this study, we aimed to investigate molecular mechanism of tumor-derived S100A14 targeting TLR4, activating astrocytes, and recruiting myeloid-derived suppressor cells (MDSCs) to promote tumor BrM and the underlying mechanisms of curdione in targeting S100A14 to suppress tumor BrM. Incubation:Article Title: Tumor-derived S100A14 targeted astrocytes via TLR4 to Recruit myeloid-derived suppressor cells promoting brain metastasis and Curdione reversal effect. Article Snippet: Background: Brain metastasis (BrM) is the most common complication with the highest mortality in clinical tumor patients.. The underlying mechanisms of S100A14 in promoting tumor BrM remains unclear, and effective therapeutic compounds targeting S100A14 are currently unavailable.. Purpose: In this study, we aimed to investigate molecular mechanism of tumor-derived S100A14 targeting TLR4, activating astrocytes, and recruiting myeloid-derived suppressor cells (MDSCs) to promote tumor BrM and the underlying mechanisms of curdione in targeting S100A14 to suppress tumor BrM. |